CK2
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    2.0379    1.4358    0.0185 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8012    0.6025    0.0122 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8747   -1.1161    0.0459 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4112    1.1111   -0.0147 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3555    0.0973    0.0116 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7891    0.4911    0.0177 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8406   -1.1910    0.0293 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5580   -2.4647   -0.0083 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3965   -3.2772    1.0540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4378   -2.7338   -1.0369 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1567   -3.8935   -0.9132 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0304   -4.7282    0.1294 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1481   -4.3843    1.0756 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0289   -5.2225    2.1413 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  3  7  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  9 13  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02091

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT00925

>  <COMMON_NAME>  (1) 
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine

>  <UNII>  (1) 
NTZ47MG2A4

$$$$
